Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats.

Oxyntomodulin (OXM) is a product of proglucagon processing in the intestine and the central nervous system. We reported that intracerebroventricular (ICV) and intranuclear administration of OXM caused an inhibition of food intake in rats (Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, and Bloom SR. Endocrinology 142: 4244-4250, 2001). In this study, we investigated the effect of twice-daily ICV administration of OXM, 1 nmol, for 7 days. A pair-fed control was included. These animals were restricted to the food intake of the OXM group but injected twice daily with saline. OXM-treated animals gained significantly less weight than either control group (day 8: OXM, 12.2 +/- 1.9 g vs. pair fed, 21.0 +/- 2.1 g; P < 0.005). OXM treatment caused a reduction in epididymal white adipose tissue (OXM, 1.13 +/- 0.03 g vs. pair fed, 1.29 +/- 0.04 g; P < 0.05) and interscapular brown adipose tissue (OXM, 0.15 +/- 0.01 g vs. pair fed, 0.18 +/- 0.01 g; P < 0.05) and increased core temperature compared with saline control, suggestive of enhanced energy expenditure. The food restriction-induced suppression in plasma TSH, seen in the pair-fed group, was prevented by OXM, potentially via increased release of hypothalamic TRH. In summary, ICV OXM causes reduced body weight gain and body adiposity following chronic administration.

[1]  J. Meites,et al.  Effects of starvation in rats on serum levels of follicle stimulating hormone, luteinizing hormone, thyrotropin, growth hormone and prolactin; response to LH-releasing hormone and thyrotropin-releasing hormone. , 1977, Endocrinology.

[2]  A. Loudon,et al.  Leptin actions on food intake and body temperature are mediated by IL-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Strader,et al.  Differential Effects of Intracerebroventricular Glucagon-Like Peptide-1 on Feeding and Energy Expenditure Regulation , 1998, Peptides.

[4]  A. Astrup,et al.  The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans , 2000, International Journal of Obesity.

[5]  S. Bloom,et al.  The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. , 1999, The Journal of endocrinology.

[6]  S. Bloom,et al.  Agouti related peptide (Agrp) stimulates the hypothalamo pituitary gonadal axis in vivo & in vitro in male rats. , 1999, Endocrinology.

[7]  Charles Watson,et al.  Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight , 1985, Journal of Neuroscience Methods.

[8]  P. Blache,et al.  Oxyntomodulin and glicentin: brain-gut peptides in the rat. , 1988, Endocrinology.

[9]  P. J. Larsen,et al.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. , 1996, The American journal of physiology.

[10]  N. H. Markussen,et al.  Metabolic depression and heat balance in starving Wistar rats. , 1986, Comparative biochemistry and physiology. A, Comparative physiology.

[11]  M. Classen,et al.  Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2. , 1996, Digestion.

[12]  W. Klootwijk,et al.  Effect of starvation and subsequent refeeding on thyroid function and release of hypothalamic thyrotropin-releasing hormone. , 1992, Neuroendocrinology.

[13]  W. Rand,et al.  a-Melanocyte-Stimulating Hormone Is Contained in Nerve Terminals Innervating Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Gene Expression , 2000 .

[14]  D. Drucker,et al.  Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro. , 1990, Endocrinology.

[15]  D. Bataille,et al.  Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin-stimulated acid secretion in rats , 1982, Bioscience reports.

[16]  A. Astrup,et al.  The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity , 2001, International Journal of Obesity.

[17]  D O'Shea,et al.  Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. , 1999, Endocrinology.

[18]  T. Severinsen,et al.  Body core temperature during food restriction in rats. , 1999, Acta physiologica Scandinavica.

[19]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[20]  D. Smith,et al.  Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. , 1996, Endocrinology.

[21]  D. Bataille,et al.  Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. , 1993 .

[22]  D L Hay,et al.  Oxyntomodulin inhibits food intake in the rat. , 2001, Endocrinology.

[23]  D. Eckland,et al.  Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. , 1991, Endocrinology.

[24]  M. Dallman,et al.  The paraventricular nucleus of the thalamus alters rhythms in core temperature and energy balance in a state-dependent manner , 1999, Brain Research.

[25]  S. Heinrichs,et al.  Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats , 2001, Brain Research.